Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cellsKyu Kwang Kim, Richard G. Moore|Scientific Reports|2015Cited by 62
Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin CKyu Kwang Kim, Richard G. Moore|BMC Cancer|2012Cited by 40
Role of trypsin and protease-activated receptor-2 in ovarian cancerKyu Kwang Kim, Richard G. Moore|PLoS ONE|2020Cited by 40
Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancersKyu Kwang Kim, Richard G. Moore|Scientific Reports|2015Cited by 22
Efficacy of a Non-Hypercalcemic Vitamin-D2 Derived Anti-Cancer Agent (MT19c) and Inhibition of Fatty Acid Synthesis in an Ovarian Cancer Xenograft ModelRichard G. Moore, Ajay Singh|PLoS ONE|2012Cited by 20